BioSpace News Archive

Business

Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer

Kite, a Gilead Company (Nasdaq: GILD), and Appia Bio, Inc. today announced a collaboration and license agreement to research and develop HSC-derived cell therapies directed toward hematological malignancies.

August 5, 2021
·
5 min read
Bio NC

9 Meters Biopharma, Inc. to participate in BMO Capital Markets’ “Biopharma Spotlight Series: Innovation in GI”

9 Meters Biopharma, Inc. (NASDAQ:NMTR), today announced that the Executive Management team will participate in the Biopharma Spotlight Series: Innovation in GI Conference Call hosted by Gary Nachman and BMO Capital Markets.

August 5, 2021
·
3 min read
NLS Pharmaceutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

NLS Pharmaceutics Ltd. announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present at the Canaccord Genuity 41 st Annual Growth Conference being held virtually August 10-12, 2021.

August 5, 2021
·
1 min read
Business

Hillstream BioPharma and Minotaur Therapeutics Sign Term Sheet to Advance Next-Generation Targeted Knob Biologics for Undruggable Targets

Hillstream BioPharma, Inc. today announced the signing of a non-binding term sheet with Minotaur Therapeutics (“Minotaur”) to advance the development of the next generation targeted Knob biologics for undruggable targets including c-MYC combined with Hillstream’s tumor-targeting Quatramers™.

August 5, 2021
·
5 min read
Business

Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update

Viveve Medical, Inc. today announced that it will report its second quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 12, 2021.

August 5, 2021
·
4 min read
Business

Capricor Therapeutics to Present Second Quarter 2021 Financial Results and Recent Corporate Update on August 12Company to Host Conference Call, August 12, 2021, at 4:30 p.m. ET

Capricor Therapeutics will release its financial results for the second quarter ended June 30, 2021, after the market close on Thursday August 12, 2021.

August 5, 2021
·
3 min read
BioMidwest

Inspired Spine has released a study of Perioperative Outcomes of Minimally Invasive Sacroiliac Joint Fusion using Hollow Screws Through a Lateral Approach.

Inspired Spine published a peer-reviewed study of perioperative outcomes of minimally invasive sacroiliac joint fusion using hollow screws through a lateral approach: A single surgeon retrospective cohort study.

August 5, 2021
·
2 min read
Policy

China Pharma’s Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

China Pharma Holdings, Inc., a specialty pharmaceutical company, announced that its Candesartan hypertension product passed key bioequivalence tests.

August 5, 2021
·
6 min read
Berry Oncology Completes Series B1 Funding, Attracting Most Venture Capital to Date in Early Cancer Screening Sector

Berry Oncology Corporation, a member company of China’s leading early cancer screening firm Berry Genomics, yesterday on its 4th anniversary, announced the completion of a US$99.15 million Series B1 financing round.

August 5, 2021
·
4 min read
Business

Synlogic Announces Second Quarter 2021 Conference Call & Participation in Upcoming Banking Conference

Synlogic, Inc.today announced the Company will release its second quarter 2021 financial results before the market opens on Thursday, August 12, 2021 .

August 5, 2021
·
3 min read